IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00862-07v1
76/2/486    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Chiavolini, D.
Right arrow Articles by Wetzler, L. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiavolini, D.
Right arrow Articles by Wetzler, L. M.
Infection and Immunity, February 2008, p. 486-496, Vol. 76, No. 2
0019-9567/08/$08.00+0     doi:10.1128/IAI.00862-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Identification of Immunologic and Pathologic Parameters of Death versus Survival in Respiratory Tularemia{triangledown}

Damiana Chiavolini,1 Joseph Alroy,2 Carol A. King,1 Peter Jorth,1 Susan Weir,1 Guillermo Madico,1 John R. Murphy,1 and Lee M. Wetzler1*

Department of Medicine, Boston University School of Medicine, Boston, Massachusetts,1 Department of Pathology-Veterinary Medicine and Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts2

Received 24 June 2007/ Returned for modification 8 August 2007/ Accepted 2 November 2007

Francisella tularensis can cause severe disseminated disease after respiratory infection. The identification of factors involved in mortality or recovery following induction of tularemia in the mouse will improve our understanding of the natural history of this disease and facilitate future evaluation of vaccine candidate preparations. BALB/c mice were infected intranasally with the live vaccine strain (LVS) of F. tularensis subsp. holarctica and euthanized at different stages of disease to analyze the induction of immune molecules, gross anatomical features of organs, bacterial burdens, and progression of the histopathological changes in lung and spleen. Tissue-specific interleukin-6 (IL-6), macrophage inflammatory protein 2, and monocyte chemotactic protein 1 were immune markers of mortality, while anti-LVS immunoglobulin M and IL-1β were associated with survival. Moribund mice had enlarged spleens and lungs, while surviving mice had even more prominent splenomegaly and normal-appearing lungs. Histopathology of the spleens of severely ill mice was characterized by disrupted lymphoid follicles and fragmented nuclei, while the spleens of survivors appeared healthy but with increased numbers of megakaryocytes and erythrocytes. Histopathology of the lungs of severely ill mice indicated severe pneumonia. Lungs of survivors at early time points showed increased inflammation, while at late times they appeared healthy with peribronchial lymphoid aggregates. Our results suggest that host immune factors are able to affect bacterial dissemination after respiratory tularemia, provide new insights regarding the pathological characteristics of pulmonary tularemia leading to systemic disease, and potentially identify immune markers associated with recovery from the disease.


* Corresponding author. Mailing address: Evans Biomedical Research Center, Boston University Medical School, 650 Albany Street, Boston, MA 02118. Phone: (617) 414-4394. Fax: (617) 414-5280. E-mail: lwetzler{at}bu.edu

{triangledown} Published ahead of print on 19 November 2007.

Editor: J. B. Bliska


Infection and Immunity, February 2008, p. 486-496, Vol. 76, No. 2
0019-9567/08/$08.00+0     doi:10.1128/IAI.00862-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.